Metabolic and Cardiovascular Effects of Armolipid Plus in Subjects With Metabolic Syndrome

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
Aim of the study is to evaluate the effects of Armolipid Plus on insulin sensitivity in patients with MetS and increased LV mass. 168 patients will be enrolled in this randomized, double-blind, parallel-group, placebo-controlled trial and treated for 24 weeks.
Epistemonikos ID: ffdded17d37fa7e1785bfbbcf896781bb843c559
First added on: May 12, 2024